Related Experiment Video
Updated: Jan 15, 2026
07:42
Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
Published on: October 13, 2015
7.9K
Trichomonas vaginalis carbonic anhydrase
1Faculty of Medicine and Health Technology, Tampere University and Department of Clinical Chemistry, Fimlab Laboratories Ltd, Tampere University Hospital, Tampere, Finland.
The Enzymes
|October 8, 2025
Summary
Trichomoniasis, a common STI, needs new treatments beyond nitroimidazoles due to potential resistance and side effects. Targeting beta-carbonic anhydrases in Trichomonas vaginalis shows promise for developing novel antiparasitic drugs.
Area of Science:
- Parasitology
- Drug Discovery
- Biochemistry
Background:
- Trichomoniasis is the most prevalent sexually transmitted infection globally, caused by the parasite Trichomonas vaginalis.
- Current treatments rely on nitroimidazoles (metronidazole, tinidazole), which are effective but associated with potential side effects and rare resistance.
- The emergence of drug resistance and side effects necessitates the development of new therapeutic agents with novel mechanisms of action.
Purpose of the Study:
- To explore novel drug targets for treating trichomoniasis.
- To investigate the potential of beta-carbonic anhydrases in Trichomonas vaginalis as therapeutic targets.
- To identify potential inhibitors for these newly characterized enzymes.
Main Methods:
- Characterization of two beta-carbonic anhydrases from T. vaginalis.
- Structural and kinetic analysis of the identified enzymes.
- Screening for potential enzyme inhibitors.
Main Results:
- Two beta-carbonic anhydrases were identified and characterized in T. vaginalis.
- Structural and kinetic properties of these enzymes were elucidated.
- Potential inhibitors targeting these beta-carbonic anhydrases were identified.
Conclusions:
- Beta-carbonic anhydrases represent promising novel drug targets for combating trichomoniasis.
- The identification of inhibitors offers a potential pathway for developing new antitrichomonal therapies.
- Further research into these targets could lead to effective treatments for this common parasitic infection.
Related Concept Videos
01:15Diversity of Protists I
850
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
850
01:25Urinary Tract Infection II: Pathophysiology
567
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
567
01:29Bacterial Phylum Chlamydiae
424
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
424
01:26Urinary Tract Infection I: Introduction
534
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
534
01:26Sexually Transmitted Infections
921
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
921
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
252
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
252